Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Finkelstein

Showing results (451-460 of 473) with videos related to

Pageof 48
Sort By:
The Lancet. Oncology|December 7, 2019
Adjuvant denosumab in early breast cancer (D-CARE): an international, multicentre, randomised, controlled, phase 3 trialRobert Coleman, Dianne M Finkelstein, Carlos Barrios, et al.
Breast Cancer Research and Treatment|August 6, 2013
Defining a threshold for intervention in breast cancer-related lymphedema: what level of arm volume increase predicts progression?Michelle C Specht, Cynthia L Miller, Tara A Russell, et al.
Journal of the National Cancer Institute|February 25, 2015
Blockade of MMP14 activity in murine breast carcinomas: implications for macrophages, vessels, and radiotherapyEleanor I Ager, Sergey V Kozin, Nathaniel D Kirkpatrick, et al.
European Journal of Cancer (Oxford, England : 1990)|February 2, 2016
Identification of early breast cancer patient cohorts who may benefit from lapatinib therapyKathrin Strasser-Weippl, Nora Horick, Ian E Smith, et al.
Breast Cancer Research : BCR|April 19, 2015
Long-term hazard of recurrence in HER2+ breast cancer patients untreated with anti-HER2 therapyKathrin Strasser-Weippl, Nora Horick, Ian E Smith, et al.
Autism : the International Journal of Research and Practice|December 8, 2017
A pilot investigation of an iOS-based app for toilet training children with autism spectrum disorderDaniel W Mruzek, Stephen McAleavey, Whitney A Loring, et al.
Cancer Research|June 18, 2024
Increased Protein Kinase A Activity Induces Fibrolamellar Hepatocellular Carcinoma Features Independent of DNAJB1Mahsa Shirani, Solomon Levin, Bassem Shebl, et al.
JCI Insight|September 8, 2022
Targeting BCL-XL in fibrolamellar hepatocellular carcinomaBassem Shebl, Denise Ng, Gadi Lalazar, et al.
The Lancet. Oncology|December 14, 2012
Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: a randomised, controlled, phase 3 trialPaul E Goss, Ian E Smith, Joyce O'Shaughnessy, et al.
Breast Cancer Research and Treatment|April 4, 2014
Long-term risk of medical conditions associated with breast cancer treatmentDeirdre A Hill, Nora K Horick, Claudine Isaacs, et al.
Pageof 48

Showing results (451-460 of 473) with videos related to

Sort By:
Pageof 48
The Lancet. Oncology|December 7, 2019
Adjuvant denosumab in early breast cancer (D-CARE): an international, multicentre, randomised, controlled, phase 3 trialRobert Coleman, Dianne M Finkelstein, Carlos Barrios, et al.
Breast Cancer Research and Treatment|August 6, 2013
Defining a threshold for intervention in breast cancer-related lymphedema: what level of arm volume increase predicts progression?Michelle C Specht, Cynthia L Miller, Tara A Russell, et al.
Journal of the National Cancer Institute|February 25, 2015
Blockade of MMP14 activity in murine breast carcinomas: implications for macrophages, vessels, and radiotherapyEleanor I Ager, Sergey V Kozin, Nathaniel D Kirkpatrick, et al.
European Journal of Cancer (Oxford, England : 1990)|February 2, 2016
Identification of early breast cancer patient cohorts who may benefit from lapatinib therapyKathrin Strasser-Weippl, Nora Horick, Ian E Smith, et al.
Breast Cancer Research : BCR|April 19, 2015
Long-term hazard of recurrence in HER2+ breast cancer patients untreated with anti-HER2 therapyKathrin Strasser-Weippl, Nora Horick, Ian E Smith, et al.
Autism : the International Journal of Research and Practice|December 8, 2017
A pilot investigation of an iOS-based app for toilet training children with autism spectrum disorderDaniel W Mruzek, Stephen McAleavey, Whitney A Loring, et al.
Cancer Research|June 18, 2024
Increased Protein Kinase A Activity Induces Fibrolamellar Hepatocellular Carcinoma Features Independent of DNAJB1Mahsa Shirani, Solomon Levin, Bassem Shebl, et al.
JCI Insight|September 8, 2022
Targeting BCL-XL in fibrolamellar hepatocellular carcinomaBassem Shebl, Denise Ng, Gadi Lalazar, et al.
The Lancet. Oncology|December 14, 2012
Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: a randomised, controlled, phase 3 trialPaul E Goss, Ian E Smith, Joyce O'Shaughnessy, et al.
Breast Cancer Research and Treatment|April 4, 2014
Long-term risk of medical conditions associated with breast cancer treatmentDeirdre A Hill, Nora K Horick, Claudine Isaacs, et al.
Pageof 48